Hasil Pencarian - Papa A Diaw

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    Establishing a national laboratory quality system for HIV diagnosis and monitoring in resource-limited settings: Experience from Senegal

    Establishing a national laboratory quality system for HIV diagnosis and monitoring in resource-limited settings: Experience from Senegal oleh Mouhamed A.S. Mbengue, Moussa Sarr, Papa A. Diaw, Papa A. N. Diallo, Maimouna D. Toure, Ndeye F.F.N. Faye, Bousso Gueye, Ndeye C.T. Kane, Souleymane Mboup

    Diterbitkan 2016-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    HIV and Tuberculosis co-infection impacts T-cell activation markers but not the numbers subset of regulatory T-cells in HIV-1 infected patients

    HIV and Tuberculosis co-infection impacts T-cell activation markers but not the numbers subset of regulatory T-cells in HIV-1 infected patients oleh Moustapha Mbow, Ndèye S.S. Santos, Makhtar Camara, Awa Ba, Aliou Niang, Géraldine Daneau, Djibril Wade, Abdou A. Diallo, Maxim Toupane, Maïmouna Diakhaté, Nafissatou Lèye, Papa A. Diaw, Souleymane Mboup, Luc Kestens, Tandakha N. Dieye

    Diterbitkan 2013-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects.

    Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects. oleh Tandakha N. Dieye, Birahim P. NDiaye, Alle B. Dieng, Marema Fall, Nathaniel Brittain, Samantha Vermaak, Makhtar Camara, Halimatou Diop-Ndiaye, Ndeye Fatou Ngom-Gueye, Papa A. Diaw, Coumba Toure-Kane, Papa S. Sow, Souleymane Mboup, Helen McShane

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naïve subjects gives comparable immunogenicity to one dose in ART+ subjects.

    Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naïve subjects gives comparable immunogenicity to one dose in ART+ subjects. oleh Tandakha N Dieye, Birahim P Ndiaye, Alle B Dieng, Marema Fall, Nathaniel Brittain, Samantha Vermaak, Makhtar Camara, Halimatou Diop-Ndiaye, Ndeye Fatou Ngom-Gueye, Papa A Diaw, Coumba Toure-Kane, Papa S Sow, Souleymane Mboup, Helen McShane

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: